Oruka Therapeutics, Inc. ($ORKA)
Filing Information
| Accession Number | 0000907654-26-000041 |
|---|---|
| Form Type | 4 |
| Filing Date | May 18, 2026 |
| Document | View SEC Filing |
Transactions
8
Total Shares
25,956
Total Value
$833,403.28
Transactions
| Name | Title | Security | Derivative | Transaction Date | Type | Shares | Price | Total Cost | Shares After | Direct/Indirect | Nature of Ownership | Actions |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
Senior Vice President, Finance | Common Stock | โ | May 18, 2026 | Exercise/Conversion | 2,000 | $12.50 | $25,000.00 | 20,863 | Direct | โ | View Details | |
Senior Vice President, Finance | Common Stock | โ | May 18, 2026 | Exercise/Conversion | 5,833 | $34.39 | $200,596.87 | 26,696 | Direct | โ | View Details | |
Senior Vice President, Finance | Common Stock | โ | May 18, 2026 | Sale | 4,190 | $58.34 | $244,465.13 | 22,506 | Direct | โ | View Details | |
Senior Vice President, Finance | Common Stock | โ | May 18, 2026 | Sale | 4,600 | $59.19 | $272,259.74 | 17,906 | Direct | โ | View Details | |
Senior Vice President, Finance | Common Stock | โ | May 18, 2026 | Sale | 800 | $60.34 | $48,269.12 | 17,106 | Direct | โ | View Details | |
Senior Vice President, Finance | Common Stock | โ | May 18, 2026 | Sale | 700 | $61.16 | $42,812.42 | 16,406 | Direct | โ | View Details | |
Senior Vice President, Finance | Employee Stock Option (right to buy) | Derivative | May 18, 2026 | Exercise/Conversion | 2,000 | $0.00 | $0.00 | 118,000 | Direct | โ | View Details | |
Senior Vice President, Finance | Employee Stock Option (right to buy) | Derivative | May 18, 2026 | Exercise/Conversion | 5,833 | $0.00 | $0.00 | 64,167 | Direct | โ | View Details |